Fig. 4
From: Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis
rhPDCD5 inhibits lymphocyte proliferation to MOG. Lymphocytes were obtained from DLNs in EAE mice treated with OVA or rhPDCD5 prophylactically (a) and therapeutically (b) at day 25 after immunization, cultured with or without MOG35–55 (20 μg/ml) for 48 h. Cell proliferation was determined by the uptake of [3H] incorporation. Data are means ± SEM (n = 8). ***P < 0.0005